As of April 2024 Fortress Biotech has a market cap of $33.66 Million. This makes Fortress Biotech the world's 7859th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $33.66 M | -24.58% |
2023 | $44.63 M | -37.26% |
2022 | $71.14 M | -71.44% |
2021 | $0.24 B | -17.12% |
2020 | $0.30 B | 57.96% |
2019 | $0.19 B | 282.44% |
2018 | $49.74 M | -75.39% |
2017 | $0.20 B | 53.16% |
2016 | $0.13 B | 0.32% |
2015 | $0.13 B | 15.95% |
2014 | $0.11 B | 8.78% |
2013 | $0.10 B | -5.23% |
2012 | $0.11 B | -8.6% |
2011 | $0.12 B |
On Apr 22nd, 2024 the market cap of Fortress Biotech was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Veracyte VCYT | $1.49 B | 4,326.85% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | $2.97 B | 8,746.31% | ๐บ๐ธ USA |
Advaxis ADXS | $24.36 M | -27.62% | ๐บ๐ธ USA |
Dynavax Technologies
DVAX | $1.54 B | 4,503.09% | ๐บ๐ธ USA |